7:00 p.m. “Medical Cannabis And Therapeutic Psychedelics” will be the topic at Shabbat services, led by Rabbi Rachlis and Cantor Braier, with guest speaker Dr. Charles Grob, a University Synagogue member and psychiatrist. Sponsored by Sharon Glickman and her family in memory of former University Synagogue president, Ron Glickman. We will also honor all those with birthdays and anniversaries this month.

There have been remarkable shifts in attitude towards particular psychotropic compounds that have historically been perceived as highly dangerous and illegal. But now, there has been increased interest in the use of marijuana products for medicinal purposes, including the treatment of nausea and vomiting associated with cancer chemotherapy, loss of appetite and weight loss associated with HIV/AIDS, epilepsy, chronic pain, muscle spasms, and agitated dementia.

More recently there has been growing interest in the therapeutic application of psychedelic drugs being studied as a potential therapeutic intervention for chronic, refractory obsessive-compulsive disorder, alcohol abuse, cigarette addiction, cocaine and crack addiction, and the demoralization and existential anxiety associated with end-of-life medical illnesses. MDMA has focused on treating patients with chronic, non-responsive post-traumatic stress disorder (PTSD) and as a treatment model for young high functioning autistic adults with severe and incapacitating social anxiety.

Charles S. Grob, M.D. is a Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and the Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center. He previously held faculty positions at the Johns Hopkins School of Medicine and the University of California at Irvine and he has conducted approved clinical research with psychedelics since the early 1990s.

Please register below.

Enter names of all attendees in the Notes section.